Ergomed aims to go private via £703m Permira takeover

UK biopharma services company Ergomed will be taken into private hands with a takeover by a subsidiary of investment group Permira that values the company at around £703 m

7 commercial, sales, and marketing predictions for 2023

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs).

Spotlight on - The Future of Oncology Clinical Trials

We present the latest insight and analysis of the rapidly evolving field of cancer therapeutics and immuno-therapy, with a particular focus on what current innovati

The 3rd Annual RNAi – Based Therapeutics Summit Returns!

Welcome to the 3rd Annual RNAi – Based Therapeutics Summit: Overcoming Barriers for Targeted siRNA Therapeutics

Next Generation Kinase Inhibitors Summit

PRISYM ID appoints Software Delivery Manager to oversee clin...

PRISYM ID appoints Software Delivery Manager to oversee te